Across TCGA pan-cancer cohorts, RPS15AP16 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RPS15AP16 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPS15AP16 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS15AP16 expression acts as an unfavorable survival marker, although some lineages such as UCS and DLBC show a favorable association.
UCEC, UCS, and MESO are the cancer types where RPS15AP16 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.